Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein. 2012

Lei Zhang, and Feng Yan, and Shengli Zhang, and Dongsheng Lei, and M Arthur Charles, and Giorgio Cavigiolio, and Michael Oda, and Ronald M Krauss, and Karl H Weisgraber, and Kerry-Anne Rye, and Henry J Pownall, and Xiayang Qiu, and Gang Ren
Molecular Foundry, Lawrence Berkeley National Laboratory, Berkeley, California, USA.

Human cholesteryl ester transfer protein (CETP) mediates the net transfer of cholesteryl ester mass from atheroprotective high-density lipoproteins to atherogenic low-density lipoproteins by an unknown mechanism. Delineating this mechanism would be an important step toward the rational design of new CETP inhibitors for treating cardiovascular diseases. Using EM, single-particle image processing and molecular dynamics simulation, we discovered that CETP bridges a ternary complex with its N-terminal β-barrel domain penetrating into high-density lipoproteins and its C-terminal domain interacting with low-density lipoprotein or very-low-density lipoprotein. In our mechanistic model, the CETP lipoprotein-interacting regions, which are highly mobile, form pores that connect to a hydrophobic central cavity, thereby forming a tunnel for transfer of neutral lipids from donor to acceptor lipoproteins. These new insights into CETP transfer provide a molecular basis for analyzing mechanisms for CETP inhibition.

UI MeSH Term Description Entries
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017434 Protein Structure, Tertiary The level of protein structure in which combinations of secondary protein structures (ALPHA HELICES; BETA SHEETS; loop regions, and AMINO ACID MOTIFS) pack together to form folded shapes. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Tertiary Protein Structure,Protein Structures, Tertiary,Tertiary Protein Structures
D053480 Cholesterol Ester Transfer Proteins Proteins that bind to and transfer CHOLESTEROL ESTERS between LIPOPROTEINS such as LOW-DENSITY LIPOPROTEINS and HIGH-DENSITY LIPOPROTEINS. Cholesterol Ester Transfer Protein,Cholesterol Ester Transport Protein, CETP,Cholesteryl Ester Exchange Protein,Cholesteryl Ester Transfer Protein

Related Publications

Lei Zhang, and Feng Yan, and Shengli Zhang, and Dongsheng Lei, and M Arthur Charles, and Giorgio Cavigiolio, and Michael Oda, and Ronald M Krauss, and Karl H Weisgraber, and Kerry-Anne Rye, and Henry J Pownall, and Xiayang Qiu, and Gang Ren
July 1998, Journal of biochemistry,
Lei Zhang, and Feng Yan, and Shengli Zhang, and Dongsheng Lei, and M Arthur Charles, and Giorgio Cavigiolio, and Michael Oda, and Ronald M Krauss, and Karl H Weisgraber, and Kerry-Anne Rye, and Henry J Pownall, and Xiayang Qiu, and Gang Ren
February 1996, Arteriosclerosis, thrombosis, and vascular biology,
Lei Zhang, and Feng Yan, and Shengli Zhang, and Dongsheng Lei, and M Arthur Charles, and Giorgio Cavigiolio, and Michael Oda, and Ronald M Krauss, and Karl H Weisgraber, and Kerry-Anne Rye, and Henry J Pownall, and Xiayang Qiu, and Gang Ren
February 1993, Journal of lipid research,
Lei Zhang, and Feng Yan, and Shengli Zhang, and Dongsheng Lei, and M Arthur Charles, and Giorgio Cavigiolio, and Michael Oda, and Ronald M Krauss, and Karl H Weisgraber, and Kerry-Anne Rye, and Henry J Pownall, and Xiayang Qiu, and Gang Ren
September 1994, European journal of clinical investigation,
Lei Zhang, and Feng Yan, and Shengli Zhang, and Dongsheng Lei, and M Arthur Charles, and Giorgio Cavigiolio, and Michael Oda, and Ronald M Krauss, and Karl H Weisgraber, and Kerry-Anne Rye, and Henry J Pownall, and Xiayang Qiu, and Gang Ren
September 1987, Journal of lipid research,
Lei Zhang, and Feng Yan, and Shengli Zhang, and Dongsheng Lei, and M Arthur Charles, and Giorgio Cavigiolio, and Michael Oda, and Ronald M Krauss, and Karl H Weisgraber, and Kerry-Anne Rye, and Henry J Pownall, and Xiayang Qiu, and Gang Ren
July 1998, Clinical chemistry,
Lei Zhang, and Feng Yan, and Shengli Zhang, and Dongsheng Lei, and M Arthur Charles, and Giorgio Cavigiolio, and Michael Oda, and Ronald M Krauss, and Karl H Weisgraber, and Kerry-Anne Rye, and Henry J Pownall, and Xiayang Qiu, and Gang Ren
September 1991, Lancet (London, England),
Lei Zhang, and Feng Yan, and Shengli Zhang, and Dongsheng Lei, and M Arthur Charles, and Giorgio Cavigiolio, and Michael Oda, and Ronald M Krauss, and Karl H Weisgraber, and Kerry-Anne Rye, and Henry J Pownall, and Xiayang Qiu, and Gang Ren
June 1999, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
Lei Zhang, and Feng Yan, and Shengli Zhang, and Dongsheng Lei, and M Arthur Charles, and Giorgio Cavigiolio, and Michael Oda, and Ronald M Krauss, and Karl H Weisgraber, and Kerry-Anne Rye, and Henry J Pownall, and Xiayang Qiu, and Gang Ren
March 1987, The Journal of biological chemistry,
Lei Zhang, and Feng Yan, and Shengli Zhang, and Dongsheng Lei, and M Arthur Charles, and Giorgio Cavigiolio, and Michael Oda, and Ronald M Krauss, and Karl H Weisgraber, and Kerry-Anne Rye, and Henry J Pownall, and Xiayang Qiu, and Gang Ren
April 1990, Lipids,
Copied contents to your clipboard!